Latest Articles
Expanding the Standard of Care: Dostarlimab for Advanced Endometrial Cancer - Pharmacy Times
Expanding the Standard of Care: Dostarlimab for Advanced Endometrial Cancer Pharmacy Times
Published: March 28, 2026, 2:58 a.m.
CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica - Via Medica Journals
CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica Via Medica Journals
Published: March 27, 2026, 12:27 p.m.
CSHL develops endometrial cancer organoid platform - Cold Spring Harbor Laboratory
CSHL develops endometrial cancer organoid platform Cold Spring Harbor Laboratory
Published: March 26, 2026, 6:59 p.m.
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism - Nature
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism Nature
Published: March 26, 2026, 6:57 a.m.
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials - AboutLawsuits.com
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials AboutLawsuits.com
Published: March 23, 2026, 4 p.m.
New Process Could Identify High Risk of Developing Endometrial Cancer - Worldwide Cancer Research
New Process Could Identify High Risk of Developing Endometrial Cancer Worldwide Cancer Research
Published: March 23, 2026, 10:38 a.m.
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence - Nature
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence Nature
Published: March 23, 2026, 8:51 a.m.
Is abnormal bleeding an early sign of endometrial cancer? | Tap to know more | Inshorts - Inshorts
Is abnormal bleeding an early sign of endometrial cancer? | Tap to know more | Inshorts Inshorts
Published: March 19, 2026, 10:07 p.m.
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com India
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com India
Published: March 19, 2026, 9 p.m.
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com
Published: March 19, 2026, 8:25 p.m.
Link copied to clipboard!